GrantGrantPrototypeMVP

SwasthyaTech Synapse 2026

IIT Delhi-linked call offering collaboration and reported funding support for prototype-stage deep-tech MedTech solutions.

0 views0 shares
in
Funding amount
Reported funding support up to INR 5 Crores; confirm the final amount and instrument in the application form
Scheme
SwasthyaTech Synapse
Open for
The call invites researchers, innovators and startups working on MedTech products and solutions. Accessible announcements present it as an Indian innovation call, but detailed incorporation and geographic conditions should be checked in the application form.
Deadline
Deadline: 30 September

About the Program

SwasthyaTech Synapse 2026 is organized by IHFC, the Technology Innovation Hub of IIT Delhi, with SET Facility at AIIMS New Delhi and Tata Elxsi. It is designed to accelerate deep-technology healthcare products through industry collaboration, technical support and funding.

Eligibility requirements

  • Applicant must be working on a MedTech product or solution.
  • Current opportunity listings describe the call as seeking working prototypes.
  • The solution should demonstrate technical feasibility and relevance to healthcare needs.
  • Detailed company-age, incorporation and intellectual-property requirements are n/a.

Offerings / Benefits

  • Reported financial support of up to INR 5 crores.
  • Collaboration with IHFC, SET Facility at AIIMS New Delhi and Tata Elxsi.
  • Technical, clinical and design expertise.
  • Potential product validation, commercialization and industry-collaboration support.
  • The funding instrument, milestone structure and amount available to each selected applicant require confirmation.

Sectors supported

Medical technology, digital health, healthcare devices, clinical solutions, healthcare robotics and other deep-tech healthcare innovations.DeepTechHealthcare & HealthTech

Selection process

  • Applications are expected to undergo technical and program evaluation by IHFC and collaborating partners. Detailed evaluation criteria, interview stages and cohort size are n/a.